血清代谢物分析揭示了使用基于LC/MS的代谢资料的败血症患者的代谢特征:一个横截面研究
Jinliang Peng1, Chongrong Qiu1, Jun Zhang1
1Department of Emergency, The Affiliated Ganzhou Hospital of Nanchang university, Ganzhou, Jiangxi Province, 341000, China.
BMC medical genomics
|September 26, 2023
概括
早期发现败血症对于患者的治疗结果至关重要. 这项研究确定了特定的血清代谢物,如PS (22:0/22:1(11Z)) 和C17-Sphinganine,作为及时毒症诊断和干预的潜在生物标志物.
科学领域:
- * 生物化学 * 生物化学
- * 临床诊断 临床诊断 临床诊断
- * 系统生物学 系统生物学
背景情况:
- * 败血症需要早期干预以改善患者的预后.
- *确定可靠的败血症生物标志物对于及时诊断至关重要.
- *血清代谢学为生物标志物发现提供了一个有前途的方法.
研究的目的:
- * 通过代谢概况识别,识别出潜在的血清败血症生物标志物.
- *为了区分败血症患者和健康个体之间的代谢特征.
- * 探索已识别的代谢物与败血症发病的关联.
主要方法:
- *分析了来自败血症患者和健康对照者的血清样本.
- * 液体染色学-质谱学 (LC-MS) 用于代谢分析.
- * 生物信息技术被用于分析代谢数据并识别差异表达的代谢物.
主要成果:
- *在败血症患者和对照人群之间观察到血清代谢物度的显著差异.
- *在败血症患者中观察到酸盐胆 (PCs),酸盐 (PS),酸盐乙醇胺 (LysoPEs) 和酸盐胆 (LysoPCs) 的水平降低.
- *在败血症患者中发现了肌素,C17-斯芬甘素和PS{22:0/22:1}{11Z}的升高水平,诊断准确度高 (AUC>0.9).
结论:
- * 特定的代谢物,包括PS (22:0/22:1(11Z)) 和C17-Sphinganine,显示出作为败血症诊断标记物的潜力.
- *代谢分析有助于理解败血症的发病因子,包括mTOR和NF-κB信号传递等途径.
- *这些生物标志物的早期识别可以促进及时的败血症诊断和干预,改善患者的治疗结果.
更多相关视频
14:42Liquid Chromatography Coupled to Refractive Index or Mass Spectrometric Detection for Metabolite Profiling in Lysate-based Cell-free Systems
Published on: September 23, 2021
4.8K
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
559
相关概念视频
MALDI-TOF Mass Spectrometry
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
